SRAMF (Sisram Medical) Interest Expense: $-3.2 Mil (TTM As of Dec. 2025)

What is Sisram Medical Interest Expense?

Sisram Medical SRAMF 60 Interest Expense is $-3.2 Mil as of Dec. 2025. GuruFocus rates SRAMF with a GF Score™ of 60/100 and a GF Value™ of $0.94 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sisram Medical's interest expense for the six months ended in Dec. 2025 was $ -1.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-3.2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sisram Medical's Operating Income for the six months ended in Dec. 2025 was $ 21.5 Mil. Sisram Medical's Interest Expense for the six months ended in Dec. 2025 was $ -1.8 Mil. Sisram Medical's Interest Coverage for the quarter that ended in Dec. 2025 was 11.86. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sisram Medical (OTCPK:SRAMF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sisram Medical's Interest Expense for the six months ended in Dec. 2025 was $-1.8 Mil. Its Operating Income for the six months ended in Dec. 2025 was $21.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $35.5 Mil.

Sisram Medical's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2025 )	/	Interest Expense (Q: Dec. 2025 )
	=	-1	*	21.502	/	-1.813
	=	11.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Sisram Medical Interest Expense Historical Data

* Premium members only.

The historical data trend for Sisram Medical's Interest Expense can be seen below:

Sisram Medical Interest Expense Chart

Sisram Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-2.01

-1.74

-2.06

-2.46

-3.25

Sisram Medical Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Interest Expense	Get a 7-Day Free Trial															-1.18	-1.18	-1.28	-1.43	-1.81

60GF Score

Sisram Medical Ltd SRAMF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sisram Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-3.2 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-3.2 Mil mean?

Sisram Medical (SRAMF) has a Interest Expense of $-3.2 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sisram Medical and its competitors.

Is Sisram Medical's Interest Expense too high?

Sisram Medical's current Interest Expense is $-3.2 Mil. Overall, Sisram Medical has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Sisram Medical's Interest Expense compare to ABT and SYK?

Sisram Medical's Interest Expense of $-3.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sisram Medical and its competitors. Sisram Medical's current Interest Expense is $-3.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sisram Medical stock overvalued right now?

Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.94, compared to a current price of $0.44 — trading 53.4% below its estimated fair value. The current Interest Expense is $-3.2 Mil. Sisram Medical's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current Interest Expense is $-3.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sisram Medical (SRAMF) Overvalued in 2026?

Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued. The current stock price of $0.44 is trading 53.4% below its estimated GF Value™ of $0.94. GuruFocus considers Sisram Medical to be Significantly Undervalued.

Key valuation signals for SRAMF:

Interest Expense: $-3.2 Mil
GF Value™: $0.94 vs. price of $0.44 (53.4% below fair value)
GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sisram Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies HKSE:06922 HKSE:02407 HKSE:02160 HKSE:02500 HKSE:06609 HKSE:01612 HKSE:06118 HKSE:02170 HKSE:02297 HKSE:02216 ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges 01696:Hong Kong

Address HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895

Website https://www.sisram-medical.com

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

60GF Score

Get the complete analysis for SRAMF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44

Price

$0.94

GF Value

View SRAMF Analysis

See Interest Expense data for all stocks →